| DC Field | Value | Language |
|---|
| dc.contributor.author | Al-Dhuraibi, A. M. | - |
| dc.contributor.author | Al-Dhuraibi, W. M. | - |
| dc.contributor.author | Abakumov, A. K. | - |
| dc.contributor.author | Soldatov, V. | - |
| dc.contributor.author | Pokrovskiy, M. V. | - |
| dc.date.accessioned | 2024-04-04T07:23:17Z | - |
| dc.date.available | 2024-04-04T07:23:17Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials / A.M. Al-Dhuraibi, W.M. Al-Dhuraibi, A.K. Abakumov [et al.] // Annals of the Romanian Society for Cell Biology. - 2021. - Vol.25, №6.-P. 20617-20634. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/61967 | - |
| dc.description.abstract | Present meta-analysis is to evaluate the safety and efficiency of Eltrombopag in the prevention and therapy of IT | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | clinical medicine | ru |
| dc.subject | eltrombopag | ru |
| dc.subject | immune thrombocytopenia ITP | ru |
| dc.subject | safety and efficacy | ru |
| dc.subject | thrombopoietin agonists | ru |
| dc.subject | meta-analysis | ru |
| dc.title | Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
